The lack of safe and effective delivery across the blood-brain barrier is one of the main hurdles to glioblastoma (GBM) therapies. Now, a combination therapy involving short bursts of radiation therapy and natural nanoparticle-based immunity has been developed by researchers at Massachusetts General Hospital (MGH).